Structure of Nutlin-3
CAS No.: 548472-68-0
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Nutlin-3 is a commercially available p53-MDM2 inhibitor with a Ki of 90 nM.
Synonyms: (±)-Nutlin-3
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 548472-68-0 |
Formula : | C30H30Cl2N4O4 |
M.W : | 581.49 |
SMILES Code : | O=C1NCCN(C(N2[C@@H](C3=CC=C(Cl)C=C3)[C@@H](C4=CC=C(Cl)C=C4)N=C2C5=CC=C(OC)C=C5OC(C)C)=O)C1 |
Synonyms : |
(±)-Nutlin-3
|
MDL No. : | MFCD07784509 |
InChI Key : | BDUHCSBCVGXTJM-UHFFFAOYSA-N |
Pubchem ID : | 216345 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H315-H319-H335 |
Precautionary Statements: | P261-P305+P351+P338 |
In Vitro:
Cell Line
|
Concentration | Treated Time | Description | References |
MOLM-13 cells | 6 µM | 0, 2, 4, 6, 8 hours | Nutlin-3 enhances p53 acetylation and increases levels of p53, MDM2, and p21 | PMC4032636 |
PAEC | 10 µM | 24 hours | Nutlin-3 increased p53 and induced the formation of the PPARγ-p53 complex, assessed by immunoprecipitation with either anti-PPARγ or anti-p53 antibodies. | PMC7908816 |
293T cells | 0.5mg/L | 24 hours | Increased p53 transcriptional activity induced by Dox was partially dependent on PPARγ. | PMC7908816 |
MDA-MB 435S (breast cancer cells) | 30 µM | 24 hours | Nutlin-3 enhances the bortezomib sensitivity of p53-defective cancer cells by inducing paraptosis, leading to cell death. | PMC5579507 |
DLD-1 (colon cancer cells) | 30 µM | 24 hours | Nutlin-3 enhances the bortezomib sensitivity of p53-defective cancer cells by inducing paraptosis, leading to cell death. | PMC5579507 |
HeLa (cervical cancer cells) | 30 µM | 24 hours | Nutlin-3 enhances the bortezomib sensitivity of p53-defective cancer cells by inducing paraptosis, leading to cell death. | PMC5579507 |
T98G (glioblastoma cells) | 30 µM | 24 hours | Nutlin-3 enhances the bortezomib sensitivity of p53-defective cancer cells by inducing paraptosis, leading to cell death. | PMC5579507 |
RT4 schwannoma cells | 0-10 μM | 24, 48, 72 hours | Nutlin-3 inhibited the proliferation of schwannoma cells through a cooperative recovery of merlin and p53, accompanied by the shuttling of both proteins from the cytoplasm to the nucleus. | PMC6197711 |
HEI-193 schwannoma cells | 0-10 μM | 24, 48, 72 hours | Nutlin-3 combined with MG-132 significantly inhibited the growth of schwannoma cells through coordinated reactivation of p53. | PMC6197711 |
SAOS-2 cells | 6 µM | 4, 6 hours | Nutlin-3 enhances p53 acetylation in SAOS-2 cells, with acetylation levels higher than the increase in total p53 levels | PMC4032636 |
H1299 cells | 6 µM | 6 hours | Nutlin-3 significantly increases p53 acetylation levels in H1299 cells, with only a small increase in total p53 levels | PMC4032636 |
94T778 cells | 10 μM | 72 hours | Nutlin-3 treatment effectively stabilized p53 and upregulated direct p53 targets MDM2, p21, and PUMA. Under these conditions, most liposarcoma cells underwent cell-cycle arrest, with approximately 20% of cells undergoing apoptosis. | PMC10391328 |
Lipo-246 cells | 10 μM | 72 hours | Nutlin-3 treatment effectively stabilized p53 and upregulated direct p53 targets MDM2, p21, and PUMA. Under these conditions, most liposarcoma cells underwent cell-cycle arrest, with approximately 20% of cells undergoing apoptosis. | PMC10391328 |
Z-138 | 5 μM | 8 h | Nutlin-3 resulted in a reduction in cell proliferation/viability, an increase in the apoptotic fraction, and cell cycle arrest | PMC7322626 |
Granta 519 | 10 μM | 8 h | Nutlin-3 resulted in a reduction in cell proliferation/viability, an increase in the apoptotic fraction, and cell cycle arrest | PMC7322626 |
MINO | 10 μM | 8 h | Nutlin-3 induced cell cycle arrest and reduced cell viability in the mutant TP53 MINO cells | PMC7322626 |
B-cell precursor acute lymphoblastic leukemia cells | 0–10 µM | To evaluate the cytotoxic effect of nutlin-3 on ALL cells with different p53 status and MDM2 expression, it was found that ALL cells with wt-p53 are sensitive to nutlin-3, while ALL cells with p53-mutant or -null phenotype are not sensitive to nutlin-3 | PMC3477706 | |
Primary acute lymphoblastic leukemia cells | 0–10 µM | To analyze the cytotoxic effect of nutlin-3 on primary ALL cells, it was found that primary ALL cells with wt-p53 are sensitive to nutlin-3, while primary ALL cells with p53 mutation are not sensitive to nutlin-3 | PMC3477706 | |
UKF-NB-3rNutlin10μM cells | 10 μM | To study the effects of RITA on p53 activation and apoptosis, results showed RITA induced p53 activation and apoptosis | PMC3358013 | |
BHK cells | 10 µM | ∼16 hours | Detection of p53-GFP ubiquitination and its inhibition by Nutlin-3 | PMC9757074 |
SJSA-1 cells | 10 μM | 2-3 weeks | Test the long-term effect of Nutlin on SJSA-1 cells, results showed no colony formation | PMC3347888 |
ARPE-19 cells | 0.1–50 μM | 24 and 48 hours | To evaluate the effects of Nutlin-3 on cell viability and proliferation. Results showed that Nutlin-3 significantly reduced cell viability and proliferation in a dose-dependent manner at both 24 and 48 hours. | PMC11018138 |
PAEC cells | 10 µM | 24 hours | Nutlin-3 increases p53 levels and induces PPARγ-p53 complex formation | PMC7908816 |
HCT116 (colon cancer cells) | 20 μM | 24 hours | Nutlin-3 enhances the bortezomib sensitivity of p53-defective cancer cells by inducing paraptosis leading to cell death. | PMC5579507 |
T98G (glioblastoma cells) | 30 μM | 24 hours | Nutlin-3 enhances the bortezomib sensitivity of p53-defective cancer cells by inducing paraptosis leading to cell death. | PMC5579507 |
HeLa (cervical cancer cells) | 30 μM | 24 hours | Nutlin-3 enhances the bortezomib sensitivity of p53-defective cancer cells by inducing paraptosis leading to cell death. | PMC5579507 |
DLD-1 (colon cancer cells) | 30 μM | 24 hours | Nutlin-3 enhances the bortezomib sensitivity of p53-defective cancer cells by inducing paraptosis leading to cell death. | PMC5579507 |
MDA-MB 435S (breast cancer cells) | 30 μM | 24 hours | Nutlin-3 enhances the bortezomib sensitivity of p53-defective cancer cells by inducing paraptosis leading to cell death. | PMC5579507 |
A549-Atg5-null | 10 μM | 24 hours | To evaluate the effect of Nutlin-3 on PD-L1 expression, results showed PD-L1 expression was higher in Atg5-null cells | PMC7457494 |
A549-Atg5-wt | 10 μM | 24 hours | To evaluate the effect of Nutlin-3 on PD-L1 expression, results showed PD-L1 expression was lower in Atg5-wt cells | PMC7457494 |
L02 cells | 10 μM | 48 hours | Nutlin-3 did not change IFI16 subcellular localization in L02 cells. | PMC4326783 |
Hep3B cells | 10 μM | 48 hours | Nutlin-3 did not induce ectopic expression of IFI16 protein in Hep3B cells. | PMC4326783 |
Huh-7 cells | 10 μM | 48 hours | Nutlin-3 did not induce ectopic expression of IFI16 protein in Huh-7 cells. | PMC4326783 |
A375 p53-null | 10 μM | 24 hours | To evaluate the effect of Nutlin-3 on cell surface expression of CD276 and PD-L1, results showed Nutlin-3 did not induce CD276 expression in p53-null cells | PMC7457494 |
A375 p53-wt | 10 μM | 24 hours | To evaluate the effect of Nutlin-3 on cell surface expression of CD276 and PD-L1, results showed Nutlin-3 induced CD276 expression in a p53-dependent manner | PMC7457494 |
HCT116 p53-null | 10 μM | 24 hours | To evaluate the effect of Nutlin-3 on cell surface expression of CD276 and PD-L1, results showed Nutlin-3 did not induce CD276 expression in p53-null cells | PMC7457494 |
HCT116 p53-wt | 10 μM | 24 hours | To evaluate the effect of Nutlin-3 on cell surface expression of CD276 and PD-L1, results showed Nutlin-3 induced CD276 expression in a p53-dependent manner | PMC7457494 |
OVCAR-3 ovarian cancer cells | 20 μM | 24 hours | OVCAR-3 cells harboring mutant p53 were not sensitized to rhTRAIL or D269H/E195R by nutlin-3, whereas cisplatin pre-treatment increased the apoptotic effect of both ligands. | PMC3833221 |
Lovo colon cancer cells | 5-20 μM | 24 hours | Nutlin-3 dose-dependently enhanced p53, p21 and MDM2 levels, indicating transcriptional activation of p53 due to the effective disruption of the MDM2–p53 interaction. DR5 protein levels and membrane expression were also increased. | PMC3833221 |
H460 non-small cell lung cancer cells | 5-20 μM | 24 hours | Nutlin-3 dose-dependently enhanced p53, p21 and MDM2 levels, indicating transcriptional activation of p53 due to the effective disruption of the MDM2–p53 interaction. DR5 protein levels and membrane expression were also increased. | PMC3833221 |
A2780 ovarian cancer cells | 5-20 μM | 24 hours | Nutlin-3 dose-dependently enhanced p53, p21 and MDM2 levels, indicating transcriptional activation of p53 due to the effective disruption of the MDM2–p53 interaction. DR5 protein levels and membrane expression were also increased. | PMC3833221 |
SJSA-1 cells | 10 μM | 3 days | Test the apoptosis-inducing effect of Nutlin on SJSA-1 cells, results showed ~40% of cells underwent apoptosis | PMC3347888 |
SAOS-2 cells | 6 μM | 4 or 6 hours | To investigate the effect of Nutlin-3 on p53 acetylation, results showed Nutlin-3 enhanced p53 acetylation | PMC4032636 |
U-2 OS cells | 5 µM | 45 hours | Nutlin-3a in combination with actinomycin D significantly enhanced FASLG-induced apoptosis. | PMC11416401 |
A549 cells | 5 µM | 45 hours | Nutlin-3a in combination with actinomycin D significantly enhanced FASLG-induced apoptosis, activating caspase-8, caspase-9, and caspase-3. | PMC11416401 |
SMMC7721/As | 20 μM | 48 hours | Combination of Nutlin-3 and arsenic trioxide significantly inhibited proliferation and induced apoptosis in SMMC7721/As cells | PMC4046148 |
HepG2/As | 20 μM | 48 hours | Combination of Nutlin-3 and arsenic trioxide significantly inhibited proliferation and induced apoptosis in HepG2/As cells | PMC4046148 |
SMMC-7721 cells | 10 μM | 48 hours | Nutlin-3 significantly increased the expression levels of IFI16 and IFNB1 mRNA, and partially redistributed chromatin-bound IFI16 protein to the cytoplasm. These effects were blocked by pretreatment with pifithrin-α, a p53 inhibitor. | PMC4326783 |
H1299 cells | 6 μM | 6 hours | To investigate the effect of Nutlin-3 on p53 acetylation, results showed Nutlin-3 enhanced p53 acetylation | PMC4032636 |
MOLM-13 cells | 6 μM | 6 hours | To investigate the effect of Nutlin-3 on p53 acetylation, results showed Nutlin-3 enhanced p53 acetylation | PMC4032636 |
UoCB6 cells | 1–10 μM | Nutlin-3 treatment led to a substantial accumulation of the p53 protein as well as the expression of its direct targets p21, MDM2 and the pro-apoptotic BAX and PUMA proteins. | PMC3948158 | |
REH cells | 1–10 μM | Nutlin-3 treatment significantly reduced viability and increased apoptosis, while inducing p21 expression, leading to an increased proportion of cells in the G0/G1 phase. | PMC3948158 | |
AT-2 cells | 1–10 μM | Nutlin-3 treatment led to a substantial accumulation of the p53 protein as well as the expression of its direct targets p21, MDM2 and the pro-apoptotic BAX and PUMA proteins. | PMC3948158 |
In Vivo:
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
Mice | EC-Bmpr2−/− mice | Intraperitoneal injection | 12 mg/kg | Daily for two weeks | Nutlin-3a restored the PPARγ-p53 complex in EC-Bmpr2?/? mice, induced target gene expression, regenerated pulmonary microvessels, and reversed pulmonary hypertension. | PMC7908816 |
Nude mice | Orthotopic hepatic tumor model | Oral | 200 mg/kg | Twice daily for 28 days | To evaluate the anti-tumor effect of Nutlin-3 combined with arsenic trioxide on orthotopic hepatic tumors in nude mice, results showed that the combination significantly inhibited tumor growth and lung metastasis. | PMC4046148 |
Mice | Lipo-246 xenograft model | Oral gavage | 37.5 mg/kg | Days 1-5 of each week for up to 3 weeks | The combination of idasanutlin and carfilzomib significantly slowed tumor growth and improved survival. | PMC10391328 |
BALB/c Nude mice | RT4 and HEI-193 schwannoma cell xenograft models | Intraperitoneal injection | 40 mg/kg | Once daily for 14 days | Nutlin-3 combined with MG-132 significantly inhibited the growth of schwannoma xenografts and induced apoptosis in tumour cells. | PMC6197711 |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
1.72mL 0.34mL 0.17mL |
8.60mL 1.72mL 0.86mL |
17.20mL 3.44mL 1.72mL |
Tags: Nutlin-3 | Nutlin3 | Nutlin 3 | MDM-2/p53 | p53-MDM2 inhibitor | E1 activating enzyme | E2 conjugating enzyme | E3 ligating enzyme | Ubiquitin activating enzyme | Ubiquitin conjugating enzyme | Ubiquitin ligase | 548472-68-0
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL